Roger Chammas, Ph.D. - Publications

Affiliations: 
2001- University of São Paulo, São Paulo, São Paulo, Brazil 
Area:
Ácidos Siálicos- Biossíntese e Função, Glicobiologia e Medicina Experimental, Glicobiologia e Matriz Extracelular

121 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 de Souza AM, Real CC, Junqueira MS, Estessi de Souza L, Navarro Marques FL, Buchpiguel CA, Chammas R, Sapienza MT, de Paula Faria D. Potential of [C]()-PK11195 PET Imaging for Evaluating Tumor Inflammation: A Murine Mammary Tumor Model. Pharmaceutics. 14. PMID 36559209 DOI: 10.3390/pharmaceutics14122715  0.7
2021 Santos NL, Bustos SO, Bhatt D, Chammas R, Andrade LNS. Tumor-Derived Extracellular Vesicles: Modulation of Cellular Functional Dynamics in Tumor Microenvironment and Its Clinical Implications. Frontiers in Cell and Developmental Biology. 9: 737449. PMID 34532325 DOI: 10.3389/fcell.2021.737449  0.302
2020 Bellan DL, Biscaia SMP, Rossi GR, Cristal AM, Gonçalves JP, Oliveira CC, Simas FF, Sabry DA, Rocha HAO, Franco CRC, Chammas R, Gillies RJ, Trindade ES. Green does not always mean go: A sulfated galactan from Codium isthmocladum green seaweed reduces melanoma metastasis through direct regulation of malignancy features. Carbohydrate Polymers. 250: 116869. PMID 33049818 DOI: 10.1016/J.Carbpol.2020.116869  0.369
2020 Lichtenstein F, Iqbal A, de Lima Will SEA, Bosch RV, DeOcesano-Pereira C, Goldfeder MB, Chammas R, Trufen CEM, Morais KLP, de Souza JG, Natalino RJM, de Azevedo IJ, Nishiyama Junior MY, Oliveira U, Alves FIA, et al. Modulation of stress and immune response by Amblyomin-X results in tumor cell death in a horse melanoma model. Scientific Reports. 10: 6388. PMID 32286411 DOI: 10.1038/S41598-020-63275-2  0.385
2020 Antunes F, Pereira GJS, Saito RF, Buri MV, Gagliardi M, Bincoletto C, Chammas R, Fimia GM, Piacentini M, Corazzari M, Smaili SS. Effective Synergy of Sorafenib and Nutrient Shortage in Inducing Melanoma Cell Death through Energy Stress. Cells. 9. PMID 32155825 DOI: 10.3390/Cells9030640  0.349
2020 Pimentel FF, Toledo JS, Gonçalves J, Alves LL, Paula MId, Andrade JMd, Tiezzi DG, Chammas R. Abstract P5-05-08: Comparative evaluation of a trastuzumab biosimilar or originator trastuzumab in association with pertuzumab: Binding and biological activities in cell culture-based assays Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-05-08  0.327
2019 Pereira JX, Dos Santos SN, Pereira TC, Cabanel M, Chammas R, de Oliveira FL, Bernardes ES, El-Cheikh MC. Galectin-3 Regulates the Expression of Tumor Glycosaminoglycans and Increases the Metastatic Potential of Breast Cancer. Journal of Oncology. 2019: 9827147. PMID 31949431 DOI: 10.1155/2019/9827147  0.423
2019 Lemos FS, Pereira JX, Carvalho VF, Bernardes ES, Chammas R, Pereira TM, Carvalho RS, Luisetto R, El-Cheikh MC, Calil-Elias S, Oliveira FL. Galectin-3 orchestrates the histology of mesentery and protects liver during lupus-like syndrome induced by pristane. Scientific Reports. 9: 14620. PMID 31601823 DOI: 10.1038/S41598-019-50564-8  0.328
2019 Andrade LNS, Otake AH, Cardim SGB, da Silva FI, Ikoma Sakamoto MM, Furuya TK, Uno M, Pasini FS, Chammas R. Extracellular Vesicles Shedding Promotes Melanoma Growth in Response to Chemotherapy. Scientific Reports. 9: 14482. PMID 31597943 DOI: 10.1038/S41598-019-50848-Z  0.429
2019 Jardim-Perassi BV, Alexandre PA, Sonehara NM, de Paula-Junior R, Reis Júnior O, Fukumasu H, Chammas R, Coutinho LL, Zuccari DAPC. RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model. Scientific Reports. 9: 966. PMID 30700756 DOI: 10.1038/S41598-018-37413-W  0.404
2018 da Silva Junior IA, de Sousa Andrade LN, Jancar S, Chammas R. Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy. Clinics (Sao Paulo, Brazil). 73: e792s. PMID 30328954 DOI: 10.6061/Clinics/2018/E792S  0.393
2018 Liberato T, Fukushima I, Kitano ES, Serrano SMT, Chammas R, Zelanis A. Proteomic profiling of the proteolytic events in the secretome of the transformed phenotype of melanocyte-derived cells using Terminal Amine Isotopic Labeling of Substrates. Journal of Proteomics. PMID 30267877 DOI: 10.1016/J.Jprot.2018.09.010  0.392
2018 Encinas G, Sabelnykova VY, de Lyra EC, Hirata Katayama ML, Maistro S, de Vasconcellos Valle PWM, de Lima Pereira GF, Rodrigues LM, de Menezes Pacheco Serio PA, de Gouvêa ACRC, Geyer FC, Basso RA, Pasini FS, Del Pilar Esteves Diz M, Brentani MM, ... ... Chammas R, et al. Somatic mutations in early onset luminal breast cancer. Oncotarget. 9: 22460-22479. PMID 29854292 DOI: 10.18632/Oncotarget.25123  0.3
2018 Bustos SO, da Silva Pereira GJ, de Freitas Saito R, Gil CD, Zanatta DB, Smaili SS, Chammas R. Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy. Oncotarget. 9: 14567-14579. PMID 29581864 DOI: 10.18632/Oncotarget.24516  0.389
2018 Favero GM, Paz JL, Otake AH, Maria DA, Caldini EG, de Medeiros RSS, Deus DF, Chammas R, Maranhão RC, Bydlowski SP. Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growthand: a preliminary report. Oncotarget. 9: 14160-14174. PMID 29581835 DOI: 10.18632/Oncotarget.24389  0.416
2018 de Oliveira FL, Dos Santos SN, Ricon L, da Costa TP, Pereira JX, Brand C, Fermino ML, Chammas R, Bernardes ES, El-Cheikh MC. Lack of galectin-3 modifies differentially Notch ligands in bone marrow and spleen stromal cells interfering with B cell differentiation. Scientific Reports. 8: 3495. PMID 29472568 DOI: 10.1038/S41598-018-21409-7  0.349
2018 Camacho X, Perroni C, de Souza Junqueira M, Fernandez M, Chammas R, Buchpiguel C, Gambini JP, Cabral P, Riva E. Cy7-Tocilizumab/Fab(Tocilizumab): Near Infrared Fluorescence In Vivo Imaging of Multiple Myeloma Blood. 132: 5621-5621. DOI: 10.1182/Blood-2018-99-114186  0.323
2018 Rangel MC, Raafat A, Castro NP, Klauzinska M, Kosakowska-Cholody T, Behbod F, Lockett S, Callahan R, Chammas R, Salomon D. Abstract B27: Tackling mammary tumors by disrupting cancer stem cells via modulation of developmental signaling pathways Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Tcm17-B27  0.403
2018 Tortelli TC, Tamura RE, Tomitao MTP, Bustos SO, Saito RdF, Leandrini SMdM, Jacomassi MD, Ribeiro U, Strauss BE, Chammas R. Abstract A67: Jarid1b protects from metformin-induced chemosensitization to cisplatin through p53 downregulation in NSCLC Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Tcm17-A67  0.338
2018 Favero GM, TCTJ, Fernandes D, Prestes AP, Kmetiuk LNB, Otake AH, Andrade LNS, Faria DdP, Carneiro CdG, Garcez AT, Marques FLN, Chammas R. Abstract A50: 7-Ketocholesterol loaded-phosphatidylserine liposome induces cell death, autophagy, and growth inhibition of melanoma and breast adenocarcinoma Clinical Cancer Research. 24: 46-46. DOI: 10.1158/1557-3265.Tcm17-A50  0.407
2018 Cirilo PDR, Côrrea BRS, Qiao M, Andrade LNS, Chammas R, Penalva LOF. Abstract A06: MicroRNA-195 acts as a tumor suppressor miRNA in human melanoma cells by targeting Prohibitin 1 Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Tcm17-A06  0.3
2018 Favero GM, Tortelli TC, Otake AH, Andrade LN, Faria DP, Carneiro CG, Garcez AT, Marques FL, Chammas R. Abstract 5130: Melanoma and breast adenocarcinoma growth inhibition by a 7-ketocholesterol loaded-phosphatidylserine liposome Cancer Research. 78: 5130-5130. DOI: 10.1158/1538-7445.Am2018-5130  0.405
2018 Saito RdF, Otake AH, Cortez MM, Gillies RJ, Chammas R. Abstract A134: Eeyarestatin I sensitizes melanoma cells to cisplatin-induced cell death Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A134  0.322
2018 Patiño AM, Junqueira MS, Zhang X, Bailey K, Ibrahim-Hashim A, Gillies RJ, Chammas R. Abstract A121: Transient increase of tumor perfusion using hypertonic saline Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A121  0.328
2017 Cirilo PDR, de Sousa Andrade LN, Corrêa BRS, Qiao M, Furuya TK, Chammas R, Penalva LOF. MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1. Bmc Cancer. 17: 750. PMID 29126391 DOI: 10.1186/S12885-017-3721-7  0.355
2017 Morais MCC, Stuhl I, Sabino AU, Lautenschlager WW, Queiroga AS, Tortelli TC, Chammas R, Suhov Y, Ramos AF. Stochastic model of contact inhibition and the proliferation of melanoma in situ. Scientific Reports. 7: 8026. PMID 28808257 DOI: 10.1038/S41598-017-07553-6  0.363
2017 Tortelli Junior TC, de Godoy LMF, de Souza GA, Bonatto D, Otake AH, de Freitas Saito R, Rosa JC, Greene LJ, Chammas R. Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death. Oncotarget. PMID 28562344 DOI: 10.18632/Oncotarget.17810  0.338
2017 Jardim-Perassi B, Sonehara N, Paula-Junior Rd, Chammas R, Coutinho L, Júnior OR, Alexandre P, Fukumasu H, Zuccari D. Abstract P1-05-28: Melatonin treatment: A transcriptomic networks in a xenograft model of breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P1-05-28  0.343
2017 Zuccari D, Junior RP, Sonehara NM, Chammas R, Raynaud F. Abstract 2504: Melatonin decreases plasma arginine, its precursors and acylcarnitines in breast cancer xenograft model at specific time point during circadian rhythm Cancer Research. 77: 2504-2504. DOI: 10.1158/1538-7445.Am2017-2504  0.342
2016 Santos SN, Junqueira MS, Francisco G, Vilanova M, Magalhães A, Baruffi MD, Chammas R, Harris AL, Reis CA, Bernardes ES. O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer. Oncotarget. PMID 27835877 DOI: 10.18632/Oncotarget.13192  0.4
2016 Vasconcelos RO, Bustos SO, Gonzalez JR, Soares CW, Barbosa MD, Chammas R, Votto AP, Trindade GS. Interaction between omega 3 PUFA and UVB radiation: Photoprotective effect in normal and tumoral murine melanocytes? Journal of Photochemistry and Photobiology. B, Biology. 164: 361-368. PMID 27736683 DOI: 10.1016/J.Jphotobiol.2016.09.043  0.387
2016 Pereira JX, Azeredo MC, Martins FS, Chammas R, Oliveira FL, Santos SN, Bernardes ES, El-Cheikh MC. The deficiency of galectin-3 in stromal cells leads to enhanced tumor growth and bone marrow metastasis. Bmc Cancer. 16: 636. PMID 27526676 DOI: 10.1186/S12885-016-2679-1  0.365
2016 Cardoso AC, Andrade LN, Bustos SO, Chammas R. Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments. Frontiers in Oncology. 6: 127. PMID 27242966 DOI: 10.3389/Fonc.2016.00127  0.434
2016 Sanches Jde S, Aguiar RB, Parise CB, Suzuki JM, Chammas R, de Moraes JZ. Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth. Cancer Science. 107: 551-5. PMID 27079440 DOI: 10.1111/Cas.12903  0.329
2016 Morais KL, Pacheco MT, Berra CM, Bosch RV, Sciani JM, Chammas R, de Freitas Saito R, Iqbal A, Chudzinski-Tavassi AM. Amblyomin-X induces ER stress, mitochondrial dysfunction, and caspase activation in human melanoma and pancreatic tumor cell. Molecular and Cellular Biochemistry. PMID 27015684 DOI: 10.1007/S11010-016-2683-4  0.357
2015 de Aguiar RB, Parise CB, Souza CR, Braggion C, Quintilio W, Moro AM, Marques FL, Buchpiguel CA, Chammas R, de Moraes JZ. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings. Cancer Letters. PMID 26655277 DOI: 10.1016/J.Canlet.2015.11.030  0.369
2015 Saito Rde F, Tortelli TC, Jacomassi MD, Otake AH, Chammas R. Emerging targets for combination therapy in melanomas. Febs Letters. 589: 3438-48. PMID 26450371 DOI: 10.1016/J.Febslet.2015.09.022  0.333
2015 Dapueto R, Aguiar RB, Moreno M, Machado CM, Marques FL, Gambini JP, Chammas R, Cabral P, Porcal W. Technetium glucose complexes as potential cancer imaging agents. Bioorganic & Medicinal Chemistry Letters. 25: 4254-9. PMID 26318991 DOI: 10.1016/J.Bmcl.2015.07.098  0.317
2015 Oliveira FL, Bernardes ES, Brand C, Dos Santos SN, Cabanel MP, Arcanjo KD, Brito JM, Borojevic R, Chammas R, El-Cheikh MC. Lack of galectin-3 up-regulates IgA expression by peritoneal B1 lymphocytes during B cell differentiation. Cell and Tissue Research. PMID 26003178 DOI: 10.1007/S00441-015-2203-Y  0.321
2015 Lindegren S, Andrade LN, Bäck T, Machado CM, Horta BB, Buchpiguel C, Moro AM, Okamoto OK, Jacobsson L, Cederkrantz E, Washiyama K, Aneheim E, Palm S, Jensen H, Tuma MC, ... Chammas R, et al. Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200. Plos One. 10: e0126298. PMID 25970341 DOI: 10.1371/Journal.Pone.0126298  0.38
2015 Leal MF, Calcagno DQ, Chung J, de Freitas VM, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients. Clinical and Experimental Medicine. 15: 415-20. PMID 25034653 DOI: 10.1007/S10238-014-0299-0  0.358
2015 Costa ET, Barnabé GF, Li M, Dias AA, Machado TR, Asprino PF, Cavalher FP, Ferreira EN, Del Mar Inda M, Nagai MH, Malnic B, Duarte ML, Leite KR, de Barros AC, Carraro DM, ... Chammas R, et al. Intratumoral heterogeneity of ADAM23 promotes tumor growth and metastasis through LGI4 and nitric oxide signals. Oncogene. 34: 1270-9. PMID 24662834 DOI: 10.1038/Onc.2014.70  0.406
2015 Encinas G, Estevez-Diz MDP, Lyra EC, Katayama MLH, Pasini FS, Maistro S, Sabelnykova V, Boutros P, Brentani MM, Basso R, Gouvea ACRCD, Chammas R, Goes JCGS, Folgueira MAAK. Somatic mutations in Luminal HER2 negative tumors from young breast cancer patients Journal of Clinical Oncology. 33: 1544-1544. DOI: 10.1200/Jco.2015.33.15_Suppl.1544  0.306
2015 Camacho X, Machado C, Garcia mF, Fernandez M, Alonso O, Cerecetto H, Chammas R, Gambini JP, Cabral P, Riva E. 99m technetium-Tocilizumab Fragments As Molecular Imaging Agent for Multiple Myeloma Blood. 126: 4214-4214. DOI: 10.1182/Blood.V126.23.4214.4214  0.371
2015 Santos DO, Chammas R, Liu FT, Loyola AM, Cardoso SV, Faria PRD. Evaluation of Wnt/Beta-Catenin and Sonic Hedgehog Signaling Pathways During Tongue Malignant Transformation in Wild-Type and Galectin-3 Deficient Mice Challenged by the Carcinogen 4NQO Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology. 119. DOI: 10.1016/J.Oooo.2014.07.524  0.312
2014 Ikemori RY, Machado CM, Furuzawa KM, Nonogaki S, Osinaga E, Umezawa K, de Carvalho MA, Verinaud L, Chammas R. Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival. Plos One. 9: e111592. PMID 25369297 DOI: 10.1371/Journal.Pone.0111592  0.433
2014 Bacchi PS, Bloise AC, Bustos SO, Zimmermann L, Chammas R, Rabbani SR. Metabolism under hypoxia in Tm1 murine melanoma cells is affected by the presence of galectin-3, a metabolomics approach. Springerplus. 3: 470. PMID 25221735 DOI: 10.1186/2193-1801-3-470  0.33
2014 Jancar S, Chammas R. PAF receptor and tumor growth. Current Drug Targets. 15: 982-7. PMID 25182608 DOI: 10.2174/1389450115666140903111812  0.422
2014 Leal MF, Cirilo PD, Mazzotti TK, Calcagno DQ, Wisnieski F, Demachki S, Martinez MC, Assumpção PP, Chammas R, Burbano RR, Smith MC. Prohibitin expression deregulation in gastric cancer is associated with the 3' untranslated region 1630 C>T polymorphism and copy number variation. Plos One. 9: e98583. PMID 24879411 DOI: 10.1371/Journal.Pone.0098583  0.315
2014 Sekiya T, Bronstein MD, Benfini K, Longuini VC, Jallad RS, Machado MC, Goncalves TD, Osaki LH, Higashi L, Viana-Jr J, Kater C, Lee M, Molatore S, Francisco G, Chammas R, et al. p27 variant and corticotropinoma susceptibility: a genetic and in vitro study. Endocrine-Related Cancer. 21: 395-404. PMID 24532476 DOI: 10.1530/Erc-13-0486  0.326
2014 Machado CM, Andrade LN, Teixeira VR, Costa FF, Melo CM, dos Santos SN, Nonogaki S, Liu FT, Bernardes ES, Camargo AA, Chammas R. Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages. Cancer Medicine. 3: 201-14. PMID 24421272 DOI: 10.1002/Cam4.173  0.422
2014 Leal MF, Mazzotti TK, Calcagno DQ, Cirilo PD, Martinez MC, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications. Bmc Gastroenterology. 14: 9. PMID 24410879 DOI: 10.1186/1471-230X-14-9  0.324
2014 da Costa PL, Sirois P, Tannock IF, Chammas R. The role of kinin receptors in cancer and therapeutic opportunities. Cancer Letters. 345: 27-38. PMID 24333733 DOI: 10.1016/J.Canlet.2013.12.009  0.346
2014 Pasini FS, Zilberstein B, Snitcovsky I, Roela RA, Mangone FR, Ribeiro U, Nonogaki S, Brito GC, Callegari GD, Cecconello I, Alves VA, Eluf-Neto J, Chammas R, Federico MH. A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma. Journal of Gastroenterology. 49: 1453-66. PMID 24217965 DOI: 10.1007/S00535-013-0904-0  0.322
2014 Camacho X, Machado C, Banchero A, García MF, Calzada V, Fernández M, Moreno M, Gambini JP, Alonso O, Chammas R, Cabral P, Riva E. Synthesis and Preliminary Assessment of 99m tc-HYNIC-Fab´s (Rituximab) for Non-Hodgkin Lymphoma Diagnosis Blood. 124: 5373-5373. DOI: 10.1182/Blood.V124.21.5373.5373  0.35
2013 Chammas R. Tumors as complex organs: are cancers manageable through the modification of their microenvironment? Bmc Proceedings. 7: K16. PMID 24764473 DOI: 10.1186/1753-6561-7-S2-K16  0.453
2013 Borges BE, Teixeira VR, Appel MH, Steclan CA, Rigo F, Filipak Neto F, da Costa Ferreira AM, Chammas R, Zanata SM, Nakao LS. De novo galectin-3 expression influences the response of melanoma cells to isatin-Schiff base copper (II) complex-induced oxidative stimulus. Chemico-Biological Interactions. 206: 37-46. PMID 23994248 DOI: 10.1016/J.Cbi.2013.08.005  0.364
2013 Pinheiro da Silva F, Medeiros MC, Dos Santos ÂB, Ferreira MA, Garippo AL, Chammas R, Caldini E, Velasco IT, Possolo de Souza H, Machado MC. Neutrophils LL-37 migrate to the nucleus during overwhelming infection. Tissue & Cell. 45: 318-20. PMID 23742816 DOI: 10.1016/J.Tice.2013.04.003  0.344
2013 Rêgo MJ, Vieira de Mello GS, da Silva Santos CA, Chammas R, Beltrão EI. Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ. Medical Molecular Morphology. 46: 92-6. PMID 23381603 DOI: 10.1007/S00795-013-0013-4  0.323
2013 Camacho X, García MF, Calzada V, Fernández M, Chabalgoity JA, Moreno M, Barbosa de Aguiar R, Alonso O, Gambini JP, Chammas R, Cabral P. [(99m)Tc(CO)(3)]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma model. Oncology. 84: 200-9. PMID 23328435 DOI: 10.1159/000338961  0.323
2013 Maria DA, de Souza JG, Morais KL, Berra CM, Zampolli Hde C, Demasi M, Simons SM, de Freitas Saito R, Chammas R, Chudzinski-Tavassi AM. A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS production. Investigational New Drugs. 31: 493-505. PMID 22975862 DOI: 10.1007/S10637-012-9871-1  0.306
2013 Lourenço LH, Chammas R. Interface of post-translational glycosylation and endoplasmic reticulum stress in melanoma: target to cancer cell sensitization to chemotherapeutic agents? Bmc Proceedings. 7: 42. DOI: 10.1186/1753-6561-7-S2-P42  0.389
2013 Saito RF, Otake AH, Cortes MM, Chammas R. Abstract B21: Endoplasmic reticulum stress conditioned melanoma cell lines to chemotherapy-induced cell death. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B21  0.333
2012 Chaves KC, Turaça LT, Pesquero JB, Mennecier G, Dagli ML, Chammas R, Schor N, Bellini MH. Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 66: 464-8. PMID 22920414 DOI: 10.1016/J.Biopha.2012.04.003  0.387
2012 Leal MF, Chung J, Calcagno DQ, Assumpção PP, Demachki S, da Silva ID, Chammas R, Burbano RR, de Arruda Cardoso Smith M. Differential proteomic analysis of noncardia gastric cancer from individuals of northern Brazil. Plos One. 7: e42255. PMID 22860099 DOI: 10.1371/Journal.Pone.0042255  0.313
2012 Brand C, Oliveira FL, Takiya CM, Palumbo A, Hsu DK, Liu FT, Borojevic R, Chammas R, El-Cheikh MC. The involvement of the spleen during chronic phase of Schistosoma mansoni infection in galectin-3-/- mice. Histology and Histopathology. 27: 1109-20. PMID 22763883 DOI: 10.14670/Hh-27.1109  0.302
2012 Gimenez M, Marie SK, Oba-Shinjo SM, Uno M, da Silva R, Laure HJ, Izumi C, Otake A, Chammas R, Rosa JC. Quantitative proteomic analysis and functional studies reveal that nucleophosmin is involved in cell death in glioblastoma cell line transfected with siRNA. Proteomics. 12: 2632-40. PMID 22745010 DOI: 10.1002/Pmic.201200034  0.339
2012 Onuchic AC, Machado CM, Saito RF, Rios FJ, Jancar S, Chammas R. Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma. Mediators of Inflammation. 2012: 175408. PMID 22570511 DOI: 10.1155/2012/175408  0.372
2012 Tortelli TC, Chammas R, Chellappan S. Abstract 5598: Interaction between BRAF inhibitor PLX-4720 and CDK inhibitors can sensitize melanoma cells with BRAF V600E mutation Cancer Research. 72: 5598-5598. DOI: 10.1158/1538-7445.Am2012-5598  0.301
2012 Carvalho RS, Nepomuceno TC, Fernandes VC, Rodrigues DC, Chammas R, Monteiro ANA, Carvalho MA. Abstract 2132: Characterization of galectin 3 as a novel BARD1 interaction partner Cancer Research. 72: 2132-2132. DOI: 10.1158/1538-7445.Am2012-2132  0.35
2012 Barnabe GF, Costa ET, Asprino PF, Nagai MH, Malnic B, Chammas R, Camargo AA. 244 Intratumoral Societies – Subpopulations of Tumor Cells Expressing Different Levels of ADAM23 Seems Responsible for Different Aspects of Malignancy European Journal of Cancer. 48. DOI: 10.1016/S0959-8049(12)70939-5  0.383
2011 Melo FH, Butera D, Junqueira Mde S, Hsu DK, da Silva AM, Liu FT, Santos MF, Chammas R. The promigratory activity of the matricellular protein galectin-3 depends on the activation of PI-3 kinase. Plos One. 6: e29313. PMID 22216245 DOI: 10.1371/Journal.Pone.0029313  0.352
2011 de Oliveira JT, de Matos AJ, Santos AL, Pinto R, Gomes J, Hespanhol V, Chammas R, Manninen A, Bernardes ES, Albuquerque Reis C, Rutteman G, Gärtner F. Sialylation regulates galectin-3/ligand interplay during mammary tumour progression--a case of targeted uncloaking. The International Journal of Developmental Biology. 55: 823-34. PMID 22161838 DOI: 10.1387/Ijdb.113359Jt  0.366
2011 Brand C, Oliveira FL, Ricon L, Fermino ML, Boldrini LC, Hsu DK, Liu FT, Chammas R, Borojevic R, Farina M, El-Cheikh MC. The bone marrow compartment is modified in the absence of galectin-3. Cell and Tissue Research. 346: 427-37. PMID 22120666 DOI: 10.1007/S00441-011-1276-5  0.312
2011 Lima LG, Oliveira AS, Campos LC, Bonamino M, Chammas R, Werneck C, Vicente CP, Barcinski MA, Petersen LC, Monteiro RQ. Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles. Thrombosis and Haemostasis. 106: 712-23. PMID 21800005 DOI: 10.1160/Th11-03-0143  0.336
2011 Oliveira FL, Brand C, Paula AA, Arcanjo KD, Hsu DK, Liu FT, Takiya CM, Borojevic R, Chammas R, El-Cheikh MC. Lack of galectin-3 disturbs mesenteric lymph node homeostasis and B cell niches in the course of Schistosoma mansoni infection. Plos One. 6: e19216. PMID 21573150 DOI: 10.1371/Journal.Pone.0019216  0.346
2011 Rocha FG, Calvo FB, Chaves KC, Peron JP, Marques RF, de Borba TR, Braga MS, Pereira CB, Vicente EJ, Chammas R, Schor N, Bellini MH. Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma. The Journal of Gene Medicine. 13: 148-57. PMID 21344541 DOI: 10.1002/Jgm.1547  0.367
2011 Werneck MB, Vieira-de-Abreu A, Chammas R, Viola JP. NFAT1 transcription factor is central in the regulation of tissue microenvironment for tumor metastasis. Cancer Immunology, Immunotherapy : Cii. 60: 537-46. PMID 21225259 DOI: 10.1007/S00262-010-0964-4  0.43
2011 Francisco G, Menezes PR, Eluf-Neto J, Chammas R. Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. International Journal of Cancer. Journal International Du Cancer. 129: 920-30. PMID 20886596 DOI: 10.1002/Ijc.25710  0.308
2011 Borges CB, Bernardes ES, Latorraca EF, Becker AP, Neder L, Chammas R, Roque-Barreira MC, Machado HR, de Oliveira RS. Galectin-3 expression: a useful tool in the differential diagnosis of posterior fossa tumors in children. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 27: 253-7. PMID 20711594 DOI: 10.1007/S00381-010-1262-3  0.372
2011 De Almeida Sant'ana JM, Mendonça DF, Chammas R, Nonogaki S, Cardoso SV, Loyola AM, De Faria PR. Expressão de galectina-3 e beta-catenina em lesões pré-malignas e carcinomatosas de língua de camundongos | Galectin-3 and beta-catenin expression in premalignant and carcinomatous lesions in tongue of mice Jornal Brasileiro De Patologia E Medicina Laboratorial. 47: 49-56. DOI: 10.1590/S1676-24442011000100007  0.321
2010 Sousa JF, Torrieri R, Silva RR, Pereira CG, Valente V, Torrieri E, Peronni KC, Martins W, Muto N, Francisco G, Brohem CA, Carlotti CG, Maria-Engler SS, Chammas R, Espreafico EM. Novel primate-specific genes, RMEL 1, 2 and 3, with highly restricted expression in melanoma, assessed by new data mining tool. Plos One. 5: e13510. PMID 20975957 DOI: 10.1371/Journal.Pone.0013510  0.33
2010 de Oliveira JT, de Matos AJ, Gomes J, Vilanova M, Hespanhol V, Manninen A, Rutteman G, Chammas R, Gärtner F, Bernardes ES. Coordinated expression of galectin-3 and galectin-3-binding sites in malignant mammary tumors: implications for tumor metastasis. Glycobiology. 20: 1341-52. PMID 20591828 DOI: 10.1093/Glycob/Cwq103  0.404
2010 Gimenez M, Souza VC, Izumi C, Barbieri MR, Chammas R, Oba-Shinjo SM, Uno M, Marie SK, Rosa JC. Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin. Proteomics. 10: 2812-21. PMID 20533335 DOI: 10.1002/Pmic.200900722  0.333
2010 Rodrigues DB, Chammas R, Malavasi NV, da Costa PL, Chura-Chambi RM, Balduino KN, Morganti L. Anti-tumor therapy with macroencapsulated endostatin producer cells. Bmc Biotechnology. 10: 19. PMID 20196841 DOI: 10.1186/1472-6750-10-19  0.427
2009 Oliveira FL, Chammas R, Ricon L, Fermino ML, Bernardes ES, Hsu DK, Liu FT, Borojevic R, El-Cheikh MC. Galectin-3 regulates peritoneal B1-cell differentiation into plasma cells. Glycobiology. 19: 1248-58. PMID 19696234 DOI: 10.1093/Glycob/Cwp120  0.315
2009 Verbisck NV, Costa ET, Costa FF, Cavalher FP, Costa MD, Muras A, Paixão VA, Moura R, Granato MF, Ierardi DF, Machado T, Melo F, Ribeiro KB, Cunha IW, Lima VC, ... ... Chammas R, et al. ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis. Cancer Research. 69: 5546-52. PMID 19549921 DOI: 10.1158/0008-5472.Can-08-2976  0.358
2009 Muras AG, Hajj GN, Ribeiro KB, Nomizo R, Nonogaki S, Chammas R, Martins VR. Prion protein ablation increases cellular aggregation and embolization contributing to mechanisms of metastasis. International Journal of Cancer. Journal International Du Cancer. 125: 1523-31. PMID 19444918 DOI: 10.1002/Ijc.24425  0.36
2009 Lima LG, Chammas R, Monteiro RQ, Moreira ME, Barcinski MA. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Letters. 283: 168-75. PMID 19401262 DOI: 10.1016/J.Canlet.2009.03.041  0.43
2008 Zhuo Y, Chammas R, Bellis SL. Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. The Journal of Biological Chemistry. 283: 22177-85. PMID 18676377 DOI: 10.1074/Jbc.M8000015200  0.351
2008 Naliwaiko K, Luvizon AC, Donatti L, Chammas R, Mercadante AF, Zanata SM, Nakao LS. Guanosine promotes B16F10 melanoma cell differentiation through PKC-ERK 1/2 pathway. Chemico-Biological Interactions. 173: 122-8. PMID 18456249 DOI: 10.1016/J.Cbi.2008.03.010  0.326
2008 De Faria PR, De Melo TL, Chammas R, Souza KCDN, Cardoso SV, Loyola AM. Study of the galectin-3 expression in tongue carcinomas of mice | Estudo da expressão de galectina-3 em carcinomas de língua de camundongos Jornal Brasileiro De Patologia E Medicina Laboratorial. 44: 221-226. DOI: 10.1590/S1676-24442008000300011  0.354
2007 Coutinho EL, Andrade LN, Chammas R, Morganti L, Schor N, Bellini MH. Anti-tumor effect of endostatin mediated by retroviral gene transfer in mice bearing renal cell carcinoma. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 3153-61. PMID 17513560 DOI: 10.1096/Fj.07-8412Com  0.395
2007 Oliveira FL, Frazão P, Chammas R, Hsu DK, Liu FT, Borojevic R, Takiya CM, El-Cheikh MC. Kinetics of mobilization and differentiation of lymphohematopoietic cells during experimental murine schistosomiasis in galectin-3 -/- mice. Journal of Leukocyte Biology. 82: 300-10. PMID 17456800 DOI: 10.1189/Jlb.1206747  0.33
2007 Lopes MTP, Sonohara S, Chammas R, Brentani MMC. Effects of steroids on laminin‐binding integrins in a human melanoma cell line International Journal of Cancer. 48: 73-80. PMID 2019459 DOI: 10.1002/Ijc.2910480114  0.362
2006 Nakahata AM, Bueno NR, Rocha HA, Franco CR, Chammas R, Nakaie CR, Jasiulionis MG, Nader HB, Santana LA, Sampaio MU, Oliva ML. Structural and inhibitory properties of a plant proteinase inhibitor containing the RGD motif. International Journal of Biological Macromolecules. 40: 22-9. PMID 16846639 DOI: 10.1016/J.Ijbiomac.2006.05.008  0.315
2006 Oba-Shinjo SM, Correa M, Ricca TI, Molognoni F, Pinhal MA, Neves IA, Marie SK, Sampaio LO, Nader HB, Chammas R, Jasiulionis MG. Melanocyte transformation associated with substrate adhesion impediment. Neoplasia (New York, N.Y.). 8: 231-41. PMID 16611417 DOI: 10.1593/Neo.05781  0.371
2006 de Souza GA, Godoy LM, Teixeira VR, Otake AH, Sabino A, Rosa JC, Dinarte AR, Pinheiro DG, Silva WA, Eberlin MN, Chammas R, Greene LJ. Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradation. Proteomics. 6: 1460-70. PMID 16429458 DOI: 10.1002/Pmic.200500243  0.365
2005 Correa M, Machado J, Carneiro CR, Pesquero JB, Bader M, Travassos LR, Chammas R, Jasiulionis MG. Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth. International Journal of Cancer. Journal International Du Cancer. 114: 356-63. PMID 15573371 DOI: 10.1002/Ijc.20673  0.424
2004 Neder L, Marie SK, Carlotti CG, Gabbai AA, Rosemberg S, Malheiros SM, Siqueira RP, Oba-Shinjo SM, Uno M, Aguiar PH, Miura F, Chammas R, Colli BO, Silva WA, Zago MA. Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas. Brain Pathology (Zurich, Switzerland). 14: 399-405. PMID 15605987 DOI: 10.1111/J.1750-3639.2004.Tb00083.X  0.342
2003 Novak EM, Metzger M, Chammas R, da Costa M, Dantas K, Manabe C, Pires J, de Oliveira AC, Bydlowski SP. Downregulation of TNF-alpha and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor. Gene Therapy. 10: 1992-7. PMID 14528323 DOI: 10.1038/Sj.Gt.3302111  0.335
2002 Villa-Verde DM, Silva-Monteiro E, Jasiulionis MG, Farias-De-Oliveira DA, Brentani RR, Savino W, Chammas R. Galectin-3 modulates carbohydrate-dependent thymocyte interactions with the thymic microenvironment. European Journal of Immunology. 32: 1434-44. PMID 11981832 DOI: 10.1002/1521-4141(200205)32:5<1434::Aid-Immu1434>3.0.Co;2-M  0.597
1996 Chammas R, Jasiulionis MG, Ventura AM, Travassos LR, Brentani RR. Laminin-binding proteins in EJ-ras-transformed fibroblasts. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Mã©Dicas E Biolã³Gicas / Sociedade Brasileira De Biofã­Sica ... [Et Al.]. 29: 1141-9. PMID 9181057  0.514
1996 Cella N, Cornejo-Uribe RR, Montes GS, Hynes NE, Chammas R. The lysosomal-associated membrane protein LAMP-1 is a novel differentiation marker for HC11 mouse mammary epithelial cells Differentiation. 61: 113-120. PMID 8983177 DOI: 10.1046/J.1432-0436.1996.6120113.X  0.344
1996 Shi WX, Chammas R, Varki A. Regulation of sialic acid 9-O-acetylation during the growth and differentiation of murine erythroleukemia cells. The Journal of Biological Chemistry. 271: 31517-25. PMID 8940167 DOI: 10.1074/Jbc.271.49.31517  0.324
1996 Jasiulionis MG, Chammas R, Ventura AM, Travassos LR, Brentani RR. alpha6beta1-Integrin, a major cell surface carrier of beta1-6-branched oligosaccharides, mediates migration of EJ-ras-transformed fibroblasts on laminin-1 independently of its glycosylation state. Cancer Research. 56: 1682-9. PMID 8603420  0.523
1995 Sjoberg ER, Chammas R, Ozawa H, Kawashima I, Khoo KH, Morris HR, Dell A, Tai T, Varki A. Expression of de-N-acetyl-gangliosides in human melanoma cells is induced by genistein or nocodazole. The Journal of Biological Chemistry. 270: 2921-30. PMID 7852370 DOI: 10.1074/Jbc.270.7.2921  0.309
1995 Veiga SS, Chammas R, Cella N, Brentani RR. Glycosylation of beta-1 integrins in B16-F10 mouse melanoma cells as determinant of differential binding and acquisition of biological activity. International Journal of Cancer. Journal International Du Cancer. 61: 420-4. PMID 7537256 DOI: 10.1002/Ijc.2910610324  0.545
1994 Chammas R, Cella N, Marques LA, Brentani RR, Hynes NE, Franco EL. Correspondence re: B. Fernandes et al., beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res., 51: 718-723, 1991. Cancer Research. 54: 306-8. PMID 8261456  0.517
1994 Chammas R, Jasiulionis MG, Cury PM, Travassos LR, Brentani RR. Functional hypotheses for aberrant glycosylation in tumor cells. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Mã©Dicas E Biolã³Gicas / Sociedade Brasileira De Biofã­Sica ... [Et Al.]. 27: 505-7. PMID 8081273  0.566
1994 Elias MC, Chammas R, Giorgi RR, Frochtengarten F, Santos CL, Brentani RR. Adhesion to laminin is down-regulated upon retinoic acid-induced F9 cell differentiation: a role for alpha 6/beta 1 integrin. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Mã©Dicas E Biolã³Gicas / Sociedade Brasileira De Biofã­Sica ... [Et Al.]. 27: 2181-4. PMID 7787801  0.529
1994 Santos CL, Giorgi RR, Frochtengarten F, Elias MC, Chammas R, Brentani RR. Regulation of vitronectin receptor expression by retinoic acid on human melanoma cells. International Journal of Clinical & Laboratory Research. 24: 148-53. PMID 7529599 DOI: 10.1007/Bf02592445  0.614
1994 Villa-Verde DM, Lagrota-Candido JM, Vannier-Santos MA, Chammas R, Brentani RR, Savino W. Extracellular matrix components of the mouse thymus microenvironment. IV. Modulation of thymic nurse cells by extracellular matrix ligands and receptors. European Journal of Immunology. 24: 659-64. PMID 7510239 DOI: 10.1002/Eji.1830240326  0.572
1993 Chammas R, Veiga SS, Travassos LR, Brentani RR. Functionally distinct roles for glycosylation of alpha and beta integrin chains in cell-matrix interactions. Proceedings of the National Academy of Sciences of the United States of America. 90: 1795-9. PMID 8446593 DOI: 10.1073/Pnas.90.5.1795  0.568
1993 Lannes-Vieira J, Chammas R, Villa-Verde DM, Vannier-dos-Santos MA, Mello-Coelho V, de Souza SJ, Brentani RR, Savino W. Extracellular matrix components of the mouse thymic microenvironment. III. Thymic epithelial cells express the VLA6 complex that is involved in laminin-mediated interactions with thymocytes. International Immunology. 5: 1421-30. PMID 8260456 DOI: 10.1093/Intimm/5.11.1421  0.609
1991 Chammas R, Veiga SS, Line S, Potocnjak P, Brentani RR. Asn-linked oligosaccharide-dependent interaction between laminin and gp120/140. An alpha 6/beta 1 integrin. The Journal of Biological Chemistry. 266: 3349-55. PMID 1993708  0.523
1991 Chammas R, Veiga SS, Brentani RR. Glycobiology of laminin-integrin interaction and the metastatic phenotype. Memã³Rias Do Instituto Oswaldo Cruz. 86: 29-35. PMID 1845245 DOI: 10.1590/S0074-02761991000700006  0.539
1991 Lopes MT, Chammas R, Brentani MMC. Laminin and fibronectin interactions with human melanoma cells: effect of glucocorticoids Memorias Do Instituto Oswaldo Cruz. 86: 121-122. PMID 1845238 DOI: 10.1590/S0074-02761991000700024  0.32
1991 Chammas R, Brentani R. Integrins and metastases: An overview Tumor Biology. 12: 309-320. PMID 1798907 DOI: 10.1159/000217732  0.607
1991 Chammas R, Brentani R, Radosevich JA, Combs SG, Rosen ST, Rasmussen B, Teisner B, Schrøder HD, Yde-Andersen E, Andersen JA, Weernink PAO, Rijksen G, Staal GEJ, Frémont S, Champigneulle B, et al. Subject Index, Vol. 12, 1991 Tumor Biology. 12: 370-370. DOI: 10.1159/000217740  0.478
1989 del Giglio A, Franco EL, Torloni H, Marques LA, Brentani MM, Arap W, Macchione M, Chammas R. Tumor and serum beta-2-microglobulin expression in women with breast cancer. American Journal of Clinical Pathology. 92: 339-42. PMID 2476028 DOI: 10.1093/Ajcp/92.3.339  0.348
Show low-probability matches.